524 related articles for article (PubMed ID: 21241519)
1. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
[TBL] [Abstract][Full Text] [Related]
2. Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
Zhao Z; Song G; Tian H; Yu Y; Tian X; Liu J; Yao S; Luo T; Qin S
Exp Biol Med (Maywood); 2012 Nov; 237(11):1262-72. PubMed ID: 23239437
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
[TBL] [Abstract][Full Text] [Related]
4. The combination of L-4F and simvastatin stimulate cholesterol efflux and related proteins expressions to reduce atherosclerotic lesions in apoE knockout mice.
Ying R; Yuan Y; Qin YF; Tian D; Feng L; Guo ZG; Sun YX; Li MX
Lipids Health Dis; 2013 Dec; 12():180. PubMed ID: 24314261
[TBL] [Abstract][Full Text] [Related]
5. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
6. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
7. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
Kosters A; Frijters RJ; Schaap FG; Vink E; Plösch T; Ottenhoff R; Jirsa M; De Cuyper IM; Kuipers F; Groen AK
J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
[TBL] [Abstract][Full Text] [Related]
8. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
[TBL] [Abstract][Full Text] [Related]
9. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
[TBL] [Abstract][Full Text] [Related]
10. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.
Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A
Circ Res; 2013 May; 112(10):1345-54. PubMed ID: 23501697
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration.
Cimmino G; Giannarelli C; Chen W; Alique M; Santos-Gallego CG; Fuster V; Hajjar RJ; Walsh CE; Badimon JJ
J Cardiovasc Pharmacol; 2011 Mar; 57(3):325-33. PubMed ID: 21164355
[TBL] [Abstract][Full Text] [Related]
13. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
[TBL] [Abstract][Full Text] [Related]
14. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
[TBL] [Abstract][Full Text] [Related]
15. Foam cells in atherosclerosis.
Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
[TBL] [Abstract][Full Text] [Related]
16. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
17. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
[TBL] [Abstract][Full Text] [Related]
18. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
[TBL] [Abstract][Full Text] [Related]
19. Effects of Chronic Whey Protein Supplementation on Atherosclerosis in ApoE
Zhang Z; Zhang R; Qin ZZ; Chen JP; Xu JY; Qin LQ
J Nutr Sci Vitaminol (Tokyo); 2018; 64(2):143-150. PubMed ID: 29710032
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
